XX
Xifeng Xu

Well Cited

28
Works
369
Citations
10
H-Index
Search Authors
Author Statistics
  • OpenAlex ID A5109410375
  • i10-Index 10
  • 2-Yr Mean Citedness 0.00
External Links
OpenAlex Profile

Xifeng Xu

Also known as: Xi-Feng Xu, XiFeng Xu, Xifeng Xu

28

Total Works

369

Citations

10

H-Index

10

i10-Index

Citation & Works Trend by Year
13 years active
Top Research Topics
Breast Cancer Treatment Studies (5) Colorectal Cancer Surgical Treatments (5) Colorectal Cancer Treatments and Studies (5) Cancer Research and Treatments (3) Gut microbiota and health (2)
Recent Publications
15 shown
Year Publication Title Citations Action
2025 Unveiling hidden players: the role of intratumoral microbiota in gastrointestinal cancer dynamics Journal of Cancer Research and Clinical Oncology 3
2025 ARNTL2 regulated the oncogene c-myc and promoted the progression of esophageal cancer through activating ANXA2 transcription Cancer Biology & Therapy 1
2025 To explore the molecular mechanisms and shared genetic characteristics of rheumatoid arthritis and cervical cancer based on multiple omics and clinical samples Discover Oncology 0
2025 The m6 A modification of CDKN2 A inhibites ferroptosis and affects the resistance of cervical squamous cell carcinoma to cisplatin Naunyn-Schmiedeberg s Archives of Pharmacology 4
2025 Metformin suppresses breast cancer cell proliferation and liver metastasis by up-regulating miR-34a World Chinese Journal of Digestology 1
2023 Cost-effectiveness of different chemotherapy strategies for high-risk stage II colon cancer World Chinese Journal of Digestology 0
2023 The predictive model for risk of chemotherapy-induced thrombocytopenia based on antineoplastic drugs for solid tumors in eastern China Scientific Reports 23
2023 The impact of age on outcomes of breast cancer in different hormone receptor and HER2 groups PLoS ONE 4
2022 An R-Based Landscape Validation of a Competing Risk Model Journal of Visualized Experiments 2
2022 An R-Based Landscape Validation of a Competing Risk Model Journal of Visualized Experiments 0
2022 Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer International Journal of Clinical Oncology 10
2021 Competing Nomogram for Late-Period Breast Cancer-Specific Death in Patients with Early-Stage Hormone Receptor-Positive Breast Cancer Clinical Breast Cancer 3
2021 The Lymph Node Ratio Optimizes Staging System while Adjuvant Chemotherapy Plays an Invalid Role for Patients with Nonmetastatic Colorectal Neuroendocrine Carcinomas: A Propensity Score Matching Analysis of Patients from the Surveillance, Epidemiology, and End-Results Database Research Square 0
2021 Distinct Microbiomes of Gut and Saliva in Patients With Systemic Lupus Erythematous and Clinical Associations Frontiers in Immunology 51
2021 A Case Report: Cutaneous Metastasis of Advanced Rectal Cancer with BRAF Mutation OncoTargets and Therapy 6

Data source: OpenAlex API